21.4 The Adaptive Immune Response: B-lymphocytes and Antibodies

B-lymphocyte Development and Activation

B-lymphocytes (B cells) are the branch of adaptive immunity responsible for producing antibodies. They develop in the bone marrow, get screened so they don't attack your own tissues, and then stand ready in lymphoid organs waiting to encounter a foreign antigen. Once activated, B cells differentiate into plasma cells that secrete large quantities of antibodies targeted against specific pathogens. Understanding how B cells mature, get activated, and produce different antibody classes is central to understanding humoral immunity.

B Cell Maturation and Tolerance

B cell maturation takes place in the bone marrow and follows a specific sequence:

1. Hematopoietic stem cells differentiate into pro-B cells.
2. Pro-B cells rearrange their immunoglobulin heavy chain genes. If rearrangement is successful, the cell becomes a pre-B cell that expresses surface IgM.
3. Pre-B cells then rearrange their immunoglobulin light chain genes. Successful rearrangement produces an immature B cell with a complete IgM molecule on its surface.
4. Immature B cells are then tested for self-reactivity before they're released into circulation as mature, naïve B cells.

That testing process is called B cell tolerance, and it prevents B cells from reacting against your own tissues. It works at two levels:

• Central tolerance (in the bone marrow): Immature B cells that bind strongly to self-antigens are either destroyed by apoptosis (programmed cell death) or undergo receptor editing, where the cell tries to rearrange its light chain genes again to produce a non-self-reactive receptor.
• Peripheral tolerance (in secondary lymphoid organs like lymph nodes and spleen): If a mature B cell encounters a self-antigen but receives no co-stimulatory signal from a T helper cell, it becomes anergic (functionally unresponsive) or undergoes apoptosis.

Activation into Plasma Cells

B cell activation requires two signals:

1. Antigen binding to the B cell receptor (BCR)
2. Co-stimulation, which can come from T helper cells or from pathogen-associated molecular patterns (PAMPs)

There are two pathways of activation depending on the type of antigen:

T-dependent activation is the more common route. The B cell internalizes the antigen, processes it, and presents peptide fragments on MHC class II molecules. A T helper cell recognizes this complex and provides co-stimulation through CD40 ligand (CD40L) binding and cytokine release. This pathway produces the strongest, longest-lasting immune responses.

T-independent activation occurs with certain antigens that can stimulate B cells without T cell help, such as bacterial polysaccharide capsules or lipopolysaccharide (LPS). These responses tend to be weaker and produce mainly IgM, with little memory cell formation.

After activation, B cells proliferate and migrate into germinal centers within secondary lymphoid organs. Inside germinal centers, two critical processes occur:

• Somatic hypermutation: Random mutations are introduced into the variable regions of antibody genes, generating B cells with slightly different antigen-binding affinities.
• Class switch recombination: The constant region of the heavy chain gene is swapped, allowing the B cell to produce a different antibody class (e.g., switching from IgM to IgG, IgA, or IgE) while keeping the same antigen specificity.

Activated B cells ultimately differentiate into two populations: plasma cells, which are short-lived antibody factories, and memory B cells, which persist long-term and mount a faster, stronger response upon re-exposure to the same antigen.

Clonal Selection and Affinity Maturation

Clonal selection is the principle that each B cell recognizes only one specific antigen. When that antigen appears, only the B cell (or small number of B cells) with the matching receptor gets activated, proliferates, and produces a clone of identical daughter cells. This is why the response is highly specific.

Affinity maturation is the process by which the average binding strength of antibodies increases over the course of an immune response. Here's how it works:

1. Inside germinal centers, somatic hypermutation generates B cells with a range of receptor affinities.
2. These mutant B cells compete for limited antigen presented on follicular dendritic cells.
3. B cells whose receptors bind the antigen most tightly receive the strongest survival signals.
4. B cells with weaker binding fail to compete and die by apoptosis.

The result is that, over days to weeks, the antibodies produced become progressively better at binding the pathogen. This is one reason your secondary immune response is not just faster but also more effective than the primary response.

Antibody Structure and Function

Antibody Structure

All antibodies share a common Y-shaped structure made of four polypeptide chains: two identical heavy chains and two identical light chains, held together by disulfide bonds.

The molecule has two functionally distinct regions:

• Fab region (fragment antigen-binding): The two "arms" of the Y. Each arm contains a variable region at its tip where the antigen-binding site is located. Because there are two arms, each antibody can bind two identical antigen molecules (or two identical epitopes).
• Fc region (fragment crystallizable): The "stem" of the Y. This is the constant region that determines which antibody class the molecule belongs to and what effector functions it can carry out (e.g., activating complement, binding to phagocyte receptors).

Antibody Classes and Functions

There are five antibody classes, each defined by a different type of heavy chain:

A helpful way to remember the order they appear: IgM is the "iMMediate" responder (produced first), and IgG is the "workhorse" that dominates the secondary response and long-term protection.

Humoral Immunity and Effector Functions

Humoral immunity refers to the antibody-mediated arm of the adaptive immune response. The term "humoral" comes from the old word for body fluids, since antibodies circulate in blood and lymph.

Antibodies don't directly kill pathogens. Instead, they contribute to pathogen clearance through three main mechanisms:

• Neutralization: Antibodies bind to surface molecules on pathogens or to toxins, physically blocking them from interacting with host cell receptors. A neutralized virus, for example, can't attach to and enter your cells.
• Opsonization: Antibodies coat the surface of a pathogen, and phagocytes (like macrophages and neutrophils) have Fc receptors that recognize the Fc region of the bound antibodies. This "tagging" dramatically enhances phagocytosis.
• Complement activation: The Fc regions of antibodies (especially IgM and IgG) bound to a pathogen surface can trigger the classical pathway of the complement cascade. This leads to formation of the membrane attack complex (MAC), which lyses the pathogen, and also generates complement fragments that further promote inflammation and opsonization.